FLC
GBT

Fifth Lane Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Fifth Lane Capital’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-117,300
Closed -$7.99M – 276
2022
Q3 		$7.99M Buy
+117,300
New +$6.47M 4.16% 5

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fifth Lane Capital's GBT Position: Q4 2022 in Review

Fifth Lane Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 117,300 shares — an estimated $7.99M sold.

Fifth Lane Capital first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $7.99M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Fifth Lane Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Fifth Lane Capital sold 117,300 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $7.99M.
  • Fifth Lane Capital first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Fifth Lane Capital's Global Blood Therapeutics, Inc. position peaked at $7.99M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Fifth Lane Capital's 13F filing for Q4 2022, filed 14 Feb 2023.